In the last year Wyeth-Lederle Vaccines and Pediatrics (a division of Wyeth-Ayerst Laboratories) has completed construction of a 115,000-sf manufacturing facility for new vaccine components, as well as new production, warehousing, administrative and central utilities buildings.